Correlation Between Eton Pharmaceuticals and Vigil Neuroscience

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Eton Pharmaceuticals and Vigil Neuroscience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eton Pharmaceuticals and Vigil Neuroscience into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eton Pharmaceuticals and Vigil Neuroscience, you can compare the effects of market volatilities on Eton Pharmaceuticals and Vigil Neuroscience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eton Pharmaceuticals with a short position of Vigil Neuroscience. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eton Pharmaceuticals and Vigil Neuroscience.

Diversification Opportunities for Eton Pharmaceuticals and Vigil Neuroscience

0.02
  Correlation Coefficient

Significant diversification

The 3 months correlation between Eton and Vigil is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Eton Pharmaceuticals and Vigil Neuroscience in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vigil Neuroscience and Eton Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eton Pharmaceuticals are associated (or correlated) with Vigil Neuroscience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vigil Neuroscience has no effect on the direction of Eton Pharmaceuticals i.e., Eton Pharmaceuticals and Vigil Neuroscience go up and down completely randomly.

Pair Corralation between Eton Pharmaceuticals and Vigil Neuroscience

Given the investment horizon of 90 days Eton Pharmaceuticals is expected to generate 0.58 times more return on investment than Vigil Neuroscience. However, Eton Pharmaceuticals is 1.71 times less risky than Vigil Neuroscience. It trades about 0.14 of its potential returns per unit of risk. Vigil Neuroscience is currently generating about 0.03 per unit of risk. If you would invest  373.00  in Eton Pharmaceuticals on August 24, 2024 and sell it today you would earn a total of  702.00  from holding Eton Pharmaceuticals or generate 188.2% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy99.6%
ValuesDaily Returns

Eton Pharmaceuticals  vs.  Vigil Neuroscience

 Performance 
       Timeline  
Eton Pharmaceuticals 

Risk-Adjusted Performance

28 of 100

 
Weak
 
Strong
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Eton Pharmaceuticals are ranked lower than 28 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Eton Pharmaceuticals displayed solid returns over the last few months and may actually be approaching a breakup point.
Vigil Neuroscience 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vigil Neuroscience has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unfluctuating performance, the Stock's technical and fundamental indicators remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.

Eton Pharmaceuticals and Vigil Neuroscience Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Eton Pharmaceuticals and Vigil Neuroscience

The main advantage of trading using opposite Eton Pharmaceuticals and Vigil Neuroscience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eton Pharmaceuticals position performs unexpectedly, Vigil Neuroscience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vigil Neuroscience will offset losses from the drop in Vigil Neuroscience's long position.
The idea behind Eton Pharmaceuticals and Vigil Neuroscience pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Complementary Tools

Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.